ANVS logo

Annovis Bio (ANVS) Company Overview

Profile

Full Name:

Annovis Bio, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 29, 2020

Indexes:

Not included

Description:

Annovis Bio (ANVS) is a biotechnology company focused on developing treatments for neurodegenerative diseases like Alzheimer's and Parkinson's. They aim to improve brain health by targeting the underlying causes of these conditions, using innovative therapies to enhance cognitive function and overall quality of life for patients.

Events Calendar

Earnings

Next earnings date:

Apr 2, 2025

Recent quarterly earnings:

Nov 8, 2024

Recent annual earnings:

Apr 2, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 10, 25 D. Boral Capital
Hold
Nov 11, 24 HC Wainwright & Co.
Buy
Nov 11, 24 D. Boral Capital
Buy
Oct 25, 24 Maxim Group
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Aug 15, 24 EF Hutton
Buy
Aug 13, 24 EF Hutton
Buy
Jul 17, 24 HC Wainwright & Co.
Buy
Jul 11, 24 HC Wainwright & Co.
Buy
Jul 2, 24 Rodman & Renshaw
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Annovis Bio?
  • Does Annovis Bio pay dividends?
  • What sector is Annovis Bio in?
  • What industry is Annovis Bio in?
  • What country is Annovis Bio based in?
  • When did Annovis Bio go public?
  • Is Annovis Bio in the S&P 500?
  • Is Annovis Bio in the NASDAQ 100?
  • Is Annovis Bio in the Dow Jones?
  • When was Annovis Bio's last earnings report?
  • When does Annovis Bio report earnings?
  • Should I buy Annovis Bio stock now?

What is the ticker symbol for Annovis Bio?

The ticker symbol for Annovis Bio is NYSE:ANVS

Does Annovis Bio pay dividends?

No, Annovis Bio does not pay dividends

What sector is Annovis Bio in?

Annovis Bio is in the Healthcare sector

What industry is Annovis Bio in?

Annovis Bio is in the Biotechnology industry

What country is Annovis Bio based in?

Annovis Bio is headquartered in United States

When did Annovis Bio go public?

Annovis Bio's initial public offering (IPO) was on January 29, 2020

Is Annovis Bio in the S&P 500?

No, Annovis Bio is not included in the S&P 500 index

Is Annovis Bio in the NASDAQ 100?

No, Annovis Bio is not included in the NASDAQ 100 index

Is Annovis Bio in the Dow Jones?

No, Annovis Bio is not included in the Dow Jones index

When was Annovis Bio's last earnings report?

Annovis Bio's most recent earnings report was on Nov 8, 2024

When does Annovis Bio report earnings?

The next expected earnings date for Annovis Bio is Apr 2, 2025

Should I buy Annovis Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions